Single-Session Extraoral PBM After Third Molar Extraction
NCT: NCT07522918 · COMPLETED
Brief Summary
Postoperative pain, edema, and trismus are frequent complications following impacted mandibular third molar surgery. This randomized controlled trial evaluated the effects of a single-session extraoral dual-wavelength photobiomodulation (PBM) (650+904 nm) applied immediately after extraction. The study aimed to assess the impact of this therapy on postoperative pain, edema, trismus, and quality of life (QoL) on days 2 and 7.
Frequently Asked Questions
What is Single-Session Extraoral PBM After Third Molar Extraction?
Single-Session Extraoral PBM After Third Molar Extraction is a clinical trial registered under NCT07522918. Current status: COMPLETED.
What is the status of NCT07522918?
The current status of NCT07522918 (Single-Session Extraoral PBM After Third Molar Extraction) is: COMPLETED.
When did Single-Session Extraoral PBM After Third Molar Extraction start?
Single-Session Extraoral PBM After Third Molar Extraction started on 2025-02-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.